688739 成大生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-0.0201.3933.5784.8417.515
总资产报酬率 ROA (%)-0.0201.3313.4064.6287.195
投入资产回报率 ROIC (%)-0.0201.3903.5694.8267.490

边际利润分析
销售毛利率 (%)74.04779.37082.93883.65087.114
营业利润率 (%)0.48112.30224.20033.01546.246
息税前利润/营业总收入 (%)-0.7129.64720.84528.80042.972
净利润/营业总收入 (%)-0.6989.47920.45226.62339.340

收益指标分析
经营活动净收益/利润总额(%)330.029126.643119.163112.11097.586
价值变动净收益/利润总额(%)478.64146.639-4.4345.7473.252
营业外收支净额/利润总额(%)-6.659-0.846-0.651-0.246-0.154

偿债能力分析
流动比率 (X)28.42122.57618.01020.31728.228
速动比率 (X)26.42420.99816.84019.13326.471
资产负债率 (%)3.3414.0234.8664.7834.039
带息债务/全部投入资本 (%)-0.666-0.736-0.802-0.976-1.100
股东权益/带息债务 (%)-14,986.788-13,550.126-12,448.351-10,216.152-9,068.384
股东权益/负债合计 (%)2,892.7482,385.9661,955.0381,990.5712,375.782
利息保障倍数 (X)0.612-3.779-6.518-6.967-13.415

营运能力分析
应收账款周转天数 (天)345.611275.271231.847225.605205.242
存货周转天数 (天)600.544586.369555.330567.585665.725